Tobias Brezina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tobias Brezina has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Alessa Lalinka Boschert
Department of Muscle and Bone Metabolism, German Aerospace Center (DLR), Institute of Aerospace Medicine, Cologne, Germany
1 shared publication - Fabian Dusse
Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
1 shared publication - Lukas Wessendorf
Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
1 shared publication Pia Wiegel
Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, University Hospital Cologne, Cologne, Germany
1 shared publication
Latest Publications
- Open Access
- 14 July 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-5
Butyricimonas faecihominis: an atypically resistant bacterium implicated in abscess formation - a case report
Background: This case report presents a unique instance of abscesses with an uncommon pathogen isolated from blood cultures. Case presentation: We present the case of a perianal abscess in a 50-year-old man with a history of cocaine abuse and bilateral hip replacements. The rapid progression led to septic shock and multi-organ failure, requiring intensive care unit admission, surgery including protective transversostomy. Blood cultures showed growth of Butyricimonas spp. with resistance to penicillin and piperacillin-tazobactam. The immediate switch to meropenem led to a significant improvement in the patient’s condition. The patient was discharged after 40 days of hospitalization in good general condition and the reversal of the transversostomy was performed six months later. Conclusion: The identification of Butyricimonas faecihominis, a rarely reported pathogen, emphasizes the challenges of diagnosing and treating unusual infections. This case emphasizes the importance of rapid microbiological diagnosis, interdisciplinary collaboration, and targeted antibiotic therapy in the treatment of abscesses and sepsis.
- 14 July 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-5
Open AccessButyricimonas faecihominis: an atypically resistant bacterium implicated in abscess formation - a case report
Background: This case report presents a unique instance of abscesses with an uncommon pathogen isolated from blood cultures. Case presentation: We present the case of a perianal abscess in a 50-year-old man with a history of cocaine abuse and bilateral hip replacements. The rapid progression led to septic shock and multi-organ failure, requiring intensive care unit admission, surgery including protective transversostomy. Blood cultures showed growth of Butyricimonas spp. with resistance to penicillin and piperacillin-tazobactam. The immediate switch to meropenem led to a significant improvement in the patient’s condition. The patient was discharged after 40 days of hospitalization in good general condition and the reversal of the transversostomy was performed six months later. Conclusion: The identification of Butyricimonas faecihominis, a rarely reported pathogen, emphasizes the challenges of diagnosing and treating unusual infections. This case emphasizes the importance of rapid microbiological diagnosis, interdisciplinary collaboration, and targeted antibiotic therapy in the treatment of abscesses and sepsis.